Curis Inc Stock Investor Sentiment

CRIS Stock  USD 4.03  0.07  1.71%   
Slightly above 68% of Curis' investor base is looking to short. The analysis of the overall investor sentiment regarding Curis Inc suggests that many traders are alarmed. Curis' investing sentiment can be driven by a variety of factors including economic data, Curis' earnings reports, geopolitical events, and overall market trends.
  

Curis Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Curis can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three months ago at www.macroaxis.com         
Acquisition by Borgman Anne Elizabeth of 4250 shares of Curis at 11.62 subject to Rule 16b-3
Macroaxis News
over three months ago at news.google.com         
How To Trade - Stock Traders Daily
Google News at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Duvall Diantha of 000 shares of Curis at 11.62 subject to Rule 16b-3
Macroaxis News
over three months ago at finance.yahoo.com         
Bispecific and Trispecific Antibodies Market to Observe Stupendous Growth by 2035, Predicts DelveIns...
Yahoo News
over three months ago at news.google.com         
Has Curis Outpaced Other Medical Stocks This Year - Yahoo Movies UK
Google News at Macroaxis
over three months ago at news.google.com         
Sarepta Therapeutics Soars Stock Rises 12.8 percent - Yahoo Movies Canada
Google News at Macroaxis
over six months ago at news.google.com         
Long Term Trading Analysis for - Stock Traders Daily
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Acquisition by Greenacre Martyn D of 4250 shares of Curis at 11.62 subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
Curis Down on FDA Partial Clinical Hold on Lymphoma Study - Yahoo Lifestyle UK
Google News at Macroaxis
over six months ago at news.google.com         
Curis Given Buy Rating at Truist Financial - Defense World
Google News at Macroaxis
over six months ago at investing.com         
Curis shares target cut by 9, retains buy rating
Investing News at Macroaxis
over six months ago at investing.com         
Curis reports progress in leukemia study with expanded patient dataset
Investing News at Macroaxis
over six months ago at finance.yahoo.com         
Curis Announces Additional Data from TakeAim Leukemia Study
Yahoo News
over six months ago at news.google.com         
Will Curis Report Negative Q1 Earnings What You Should Know - Yahoo Canada Shine On
Google News at Macroaxis
over six months ago at news.google.com         
Curis Earns Buy Rating from HC Wainwright - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Curis that are available to investors today. That information is available publicly through Curis media outlets and privately through word of mouth or via Curis internal channels. However, regardless of the origin, that massive amount of Curis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Curis news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Curis relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Curis' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Curis alpha.

Curis Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 2406 shares by James Dentzer of Curis at 3.18 subject to Rule 16b-3
09/19/2024
2
Acquisition by Borgman Anne Elizabeth of 25000 shares of Curis subject to Rule 16b-3
10/11/2024
3
Curis looks to raise 12.1M in private placement
10/29/2024
4
Curis Inc. Stock Surges 5.08 percent Amid Strong Biotech Sector Performance
11/05/2024
5
Earnings call Rigel Pharmaceuticals reports strong Q3 growth, plans expansion
11/08/2024
6
Mersana Therapeutics, Inc. Reports Q3 Loss, Tops Revenue Estimates
11/13/2024
7
Curis GAAP EPS of -1.70 beats by 0.17, revenue of 2.93M beats by 0.56M
11/14/2024
8
Curis, Inc. Q3 2024 Earnings Call Transcript
11/15/2024
9
Curis Q3 Earnings Snapshot - Marketscreener.com
11/21/2024

Additional Tools for Curis Stock Analysis

When running Curis' price analysis, check to measure Curis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curis is operating at the current time. Most of Curis' value examination focuses on studying past and present price action to predict the probability of Curis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curis' price. Additionally, you may evaluate how the addition of Curis to your portfolios can decrease your overall portfolio volatility.